Manufacturer record
Bindlysh Biotec Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Bindlysh Biotec Ltd (Delhi) was declared Not of Standard Quality in January 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: LXB-003, Terbutaline Sulphate, Bromhexine Hydrochloride, Guaiphenesin & Menthol Syrup (exp Jul 2027). RDTL, Chandigarh (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Bromhexine Hydrochloride. Listed in the January 2026 alert.
Records by type
1 record linked to Bindlysh Biotec Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Terbutaline Sulphate, Bromhexine Hydrochloride, Guaiphenesin & Menthol Syrup | Batch LXB-003Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Bromhexine HydrochlorideAssay | RDTL, ChandigarhCDSCO lab | Jan 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.